Dr Paula Rodríguez Otero is a consultant, deputy professor and member of the Myeloma Unit at the University of Navarra in Pamplona, Spain. She is medical responsible of the Clinical Trial Unit at Clínica Universidad de Navarra, where she has led the clinical trials and immunotherapy programme since 2011, under the direction of Professor Jesus San Miguel. She studied medicine at the University of Navarra, completed her residency in haematology at the University Hospital of Navarra, and joined the Faculty of Medicine at the same institution in 2011. From 2009 until 2011, after completing her PhD, she undertook a clinical fellowship in the Bone Marrow Transplant Division at the Hôpital Saint-Louis in Paris, France.

Dr Rodríguez Otero’s research interests include the management, treatment and biology of multiple myeloma, and new immunotherapy strategies. She has collaborated in >50 oncology/haematology clinical trials and several translational research projects, leading to the approval of some novel T-cell redirecting therapies. She is an active participant in the International Myeloma Working Group immunotherapy committee and has led the development of international guidelines for managing patients treated with bispecific antibodies.

Dr Rodríguez Otero has published articles in high-impact haematology journals and has presented at national and international congresses.